NBI-921352
NBI-921352-DEE2013
Phase 2 small_molecule active
Quick answer
NBI-921352 for SCN8A Developmental and Epileptic Encephalopathy Syndrome is a Phase 2 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- SCN8A Developmental and Epileptic Encephalopathy Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active